# Glycosylated Hemoglobin and Risk of Perioperative Major Cardiovascular Events in Diabetic Patients Undergoing Coronary Bypass Revascularization (HbA1c)

> **NCT03590223** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 589 (actual)

## Conditions studied

- Cardiovascular Event
- Coronary Artery Bypass Graft
- Diabetes Mellitus

## Interventions

- **PROCEDURE:** Coronary Bypass Revascularization

## Key facts

- **NCT ID:** NCT03590223
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-29
- **Primary completion:** 2018-08-21
- **Final completion:** 2018-08-21
- **Target enrollment:** 589 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03590223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03590223, "Glycosylated Hemoglobin and Risk of Perioperative Major Cardiovascular Events in Diabetic Patients Undergoing Coronary Bypass Revascularization (HbA1c)". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03590223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*